Authors:
Ma, Y
Lang, LX
Kiesewetter, DO
Jagoda, E
Sassaman, MB
Der, M
Eckelman, WC
Citation: Y. Ma et al., Liquid chromatography-tandem mass spectrometry identification of metabolites of two 5-HT1A antagonists, N-{2-[4-(2-methoxylphenyl)piperazino]ethyl}-N-(2-pyridyl) trans- and cis-4-fluorocyclohexanecarboxamide, produced by human and rat hepatocytes, J CHROMAT B, 755(1-2), 2001, pp. 47-56
Authors:
Yordanov, AT
Garmestani, K
Zhang, M
Zhang, Z
Yao, Z
Phillips, KE
Herring, B
Horak, E
Beitzel, MP
Schwarz, UP
Gansow, OA
Plascjak, PS
Eckelman, WC
Waldmann, TA
Brechbiel, MW
Citation: At. Yordanov et al., Preparation and in vivo evaluation of linkers for At-211 labeling of humanized anti-Tac, NUCL MED BI, 28(7), 2001, pp. 845-856
Citation: Dr. Vera et Wc. Eckelman, Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers, NUCL MED BI, 28(5), 2001, pp. 475-476
Authors:
Tian, XR
Hsin, LW
Webster, EL
Contoreggi, C
Chrousos, GP
Gold, PW
Habib, K
Ayala, A
Eckelman, WC
Jacobson, AE
Rice, KC
Citation: Xr. Tian et al., The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type1, BIOORG MED, 11(3), 2001, pp. 331-333
Authors:
Yao, ZS
Garmestani, K
Wong, KJ
Park, LS
Dadachova, E
Yordanov, A
Waldmann, TA
Eckelman, WC
Paik, CH
Carrasquillo, JA
Citation: Zs. Yao et al., Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody, J NUCL MED, 42(10), 2001, pp. 1538-1544
Authors:
Smith, MF
Daube-Witherspoon, ME
Plascjak, PS
Szajek, LP
Carson, RE
Everett, JR
Green, SL
Territo, PR
Balaban, RS
Bacharach, SL
Eckelman, WC
Citation: Mf. Smith et al., Device-dependent activity estimation and decay correction of radionuclide mixtures with application to Tc-94m PET studies, MED PHYS, 28(1), 2001, pp. 36-45
Authors:
Carson, RE
Lan, LX
Watabe, H
Der, MG
Adams, HR
Jagoda, E
Herscovitch, P
Eckelman, WC
Citation: Re. Carson et al., PET evaluation of [F-18]FCWAY, an analog of the 5-HT1A receptor antagonist, WAY-100635, NUCL MED BI, 27(5), 2000, pp. 493-497
Authors:
Hsin, LW
Webster, EL
Chrousos, GP
Gold, PW
Eckelman, WC
Contoreggi, C
Rice, KC
Citation: Lw. Hsin et al., Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor, BIOORG MED, 10(8), 2000, pp. 707-710
Authors:
Hsin, LW
Webster, EL
Chrousos, GP
Gold, PW
Eckelman, WC
Contoreggi, C
Rice, KC
Citation: Lw. Hsin et al., Synthesis of [H-3] (4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor, J LABEL C R, 43(9), 2000, pp. 899-908
Authors:
Shoaf, SE
Carson, RE
Hommer, D
Williams, WA
Higley, JD
Schmall, B
Herscovitch, P
Eckelman, WC
Linnoila, M
Citation: Se. Shoaf et al., The suitability of [C-11]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: Studies with dual administration of [C-11] and [C-14] labeled tracer, J CEREBR B, 20(2), 2000, pp. 244-252
Authors:
Watabe, H
Endres, CJ
Breier, A
Schmall, B
Eckelman, WC
Carson, RE
Citation: H. Watabe et al., Measurement of dopamine release with continuous infusion of [C-11]raclopride: Optimization and signal-to-noise considerations, J NUCL MED, 41(3), 2000, pp. 522-530
Authors:
Kling, MA
Carson, RE
Borg, L
Zametkin, A
Matochik, JA
Schluger, J
Herscovitch, P
Rice, KC
Ho, A
Eckelman, WC
Kreek, MJ
Citation: Ma. Kling et al., Opioid receptor imaging with positron emission tomography and [F-18]cyclofoxy in long-term, methadone-treated former heroin addicts, J PHARM EXP, 295(3), 2000, pp. 1070-1076
Authors:
Kiesewetter, DO
Sassaman, MB
Robbins, J
Jagoda, EM
Carson, RE
Appel, NM
Sutkowski, E
Herscovitch, P
Braun, A
Eckelman, WC
Citation: Do. Kiesewetter et al., Synthesis and evaluation of an F-18 analog of forskolin for imaging adenylyl cyclase, J FLUORINE, 101(2), 2000, pp. 297-304